XML 82 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes [Abstract]  
Schedule of Income (loss) Before Provision for Income Taxes

Income (loss) before provision for income taxes consisted of the following:

 

   December 31, 
   2025   2024 
   (In thousands) 
Domestic $(8,985) $(30,356)
Foreign      
Loss before provision for income taxes $(8,985) $(30,356)
Schedule of Statutory Income Tax Rates and Effective Tax Rate

A reconciliation of the Company’s statutory income tax rate to the Company’s effective income tax rate is as follows:

 

   December 31, 
   2025   2024 
Income at US statutory rate  21.00%  21.00%
State taxes, net of federal benefit  0.00%  (0.19)%
Direct listing offering costs  (2.72)%  0.00%
Recapitalization of common stock  0.00%  (17.99)%
Tax credits  0.35%  0.02%
Valuation allowance  (18.63)%  (2.84)%
   0.00%  0.00%
Schedule of Net Deferred Income Tax Asset Balance

The net deferred income tax asset balance related to the following:

 

   December 31, 
   2025   2024 
   (In thousands) 
Net operating loss carryforwards $4,742  $4,096 
Gene therapy patent license  852    
Credits  50   19 
Capitalized research and development  998   1,217 
Total deferred tax assets  6,642   5,332 
Valuation allowance  (6,392)  (4,865)
Net deferred tax assets $250  $467 
Deferred tax liabilities          
Accruals and other  (250)  (467)
Net deferred tax liabilities  (250)  (467)
Net deferred tax assets (liabilities) $  $